Aurora, CONCT05775718Now EnrollingIRB Ready

Bone Marrow Transplant Clinical Trial in Aurora, CO

Access cutting-edge bone marrow transplant treatment through this phase 2 clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by University of Colorado, Denver

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions…

Expert Care in Aurora

Access bone marrow transplant specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bone marrow transplant treatment provided free

Apply for This Aurora Location

Check if you qualify for this bone marrow transplant clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This Bone Marrow Transplant Study in Aurora

This research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity and safety in people who have undergone allogeneic stem cell transplant (allo-SCT). Specifically, it will determine the effect of the interval after transplantation on the immune response and if an additional dose of vaccine is needed to improve the vaccine-induced responses.

Sponsor: University of Colorado, Denver

Who Can Participate

Inclusion Criteria

Allo-SCT recipients being age 18 - 79 years at time of allo-SCT.
Written informed consent being obtained from the subject
Two doses of RZV, separated by 2 to 6 months, administered at least 1 year after allo-SCT.
Enrollment at \>/= 18 months after second dose of Shingrix.
Female subjects of childbearing potential (FOCBP) enrolled in the study only if they:
have practiced adequate contraception for 30 days prior to vaccination with any dose of zoster vaccine and
have a negative pregnancy test on the day of each dose of zoster vaccine and
agree to continue adequate contraception during the vaccination period and for 2 months after receipt of the vaccine.
Investigator belief that the participant will comply with the requirements of the protocol

Exclusion Criteria

Active Graft Versus Host Disease (aGVHD) at the time of enrollment and receipt of the third dose of RZV
Having received ≥20 mg prednisone for more than 2 weeks (or equivalent) in the 8 weeks preceding enrollment.
Receiving any significant immunosuppressive therapy other than for graft maintenance, in the opinion of the investigator.
Having received a live attenuated vaccine within the last 4 weeks, or inactivated vaccine in the last 2 weeks, prior to enrollment.
Having a history of HZ after the administration of the primary 2-dose RZV immunization regimen.
Pregnancy or breastfeeding
Receiving investigational drugs from 30 day before enrollment or planned during the study
Inability of participants unable to comply with the study schedule in the opinion of the investigator

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT05775718) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Bone Marrow Transplant Treatment Options in Aurora, CO

If you're searching for bone marrow transplant treatment options in Aurora, CO, this clinical trial (NCT05775718) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced bone marrow transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bone marrow transplant clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Aurora, CO

See all rheumatoid arthritis clinical trials recruiting in Aurora — not just this study.

Browse Rheumatoid Arthritis Trials in Aurora →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO